A comparison of analytic procedures for measurement of fractional dextran clearances

Journal of Laboratory and Clinical Medicine

Volumn 132, Issue 5, 1998, Pages 390-403

  Hemmelder, Marc H ^b   De Jong, Paul E ^b   De Zeeuw, Dick ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032213152     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90110-X     Document Type: Article

References (57)

1. Chang RLS, Ueki IF, Troy JL, Deen WM, Robertson CR, Brenner BM. Permselectivity of the glomerular capillary wall to macromolecules: II. Experimental studies in rats using neutral dextran. Biophys J 1975;15:887-95.
2. Rennke HG, Cotran RS, Venkatachalam MA. Role of molecular charge in glomerular permeability. J Cell Biol 1975;67:638-46.
3. Chang RLS, Deen WM, Robertson CR, Bennet CM, Glassock RJ, Brenner BM. Permselectivity of the glomerular capillairy wall: studies of experimental glomerulonephritis in the rat using neutral dextran. J Clin Invest 1976;52:1272-80.
4. Mogensen CE. The glomerular permeability determined by dextran clearance using sephadex gel filtration. Scan J Clin Lab Invest 1968;21:77-82.
5. Mogensen CE. Kidney function and glomerular permeability to macromolecules in early juvenile diabetes. Scan J Clin Lab Invest 1971;28:79-90.
6. Carrie BJ, Hilberman M, Schroeder JS, Myers BD. Albuminuria and the permselective properties of the glomerulus in cardiac failure. Kidney Int 1980;17:507-14.
7. Carrie BJ, Myers BD. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy. Kidney Int 1980;17:669-76.
8. Carrie BJ, Salyer WR, Myers BD. Minimal change nephropathy: an electrochemical disorder of the glomerular membrane. Am J Med 1981;70:262-8.
9. Winetz JA, Robertson CR, Golbetz HV, Carrie BJ, Salyer WR, Myers BD. The nature of the glomerular injury in minimal change and focal sclerosing glomerulopathies. Am J Kidney Dis 1981;1:91-8.
10. Winetz JA, Golbetz HV, Spencer RJ, Lee JA, Myers BD. Glomerular function in advanced human diabetic nephropathy. Kidney Int 1982;21:750-6.
11. Myers BD, Okarma TB, Friedman S, Bridges C, Ross J, Asseff S, et al. Mechanisms of proteinuria in human glomerulonephritis. J Clin Invest 1982;70:732-46.
12. Myers BD, Winetz JA, Chui F, Michaels AS. Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function. Kidney Int 1982;21:96-105.
13. Friedmann S, Jones HW, Golbetz HV, Lee JA, Little HL, Myers BD. Mechanisms of proteinuria in diabetic nephropathy: II. A study of the size-selective glomerular filtration barrier. Diabetes 1983;32(suppl 2):40-6.
14. Deen WM, Bridges CR, Brenner BM, Myers BD. Heteroporous model of glomerular size selectivity: application to normal and nephrotic humans. Am J Physiol 1985;249:F374-89.
15. Shemesh O, Ross JC, Deen WM, Grant GW, Myers BD. Nature of the glomerular capillary injury in human membranous glomerulopathy. J Clin Invest 1986;77:868-77.
16. Shemesh O, Deen WM, Brenner BM, McNeely E, Myers BD. Effect of colloid volume expansion on glomerular barrier size-selectivity in humans. Kidney Int 1986;29:916-23.
17. Tomlanovich S, Deen WM, Jones HW, Schwartz HC, Myers BD. Functional nature of glomerular injury in progressive diabetic glomerulopathy. Diabetes 1987;36:556-65.
18. Rosenberg ME, Swanson JE, Leppala Thomas B, Hostetter TH. Glomerular and hormonal responses to dietary protein intake in human renal disease. Am J Physiol 1987;253:F1083-90.
19. Ala-Houhala I, Pasternack A. Fractional dextran and protein clearances in glomerulonephritis and in diabetic nephropathy. Clin Sci 1987;72:289-96.
20. Ala-Houhala I, Vapaatalo H, Pasternack A. Intravenously administered furosemide increases glomerular permeability. Clin Sci 1987;73:365-70.
21. Nakamura Y, Myers BD. Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes 1988;37:1202-11.
22. Chan AYM, Cheng MLL, Keil LC, Myers BD. Functional responses of healthy and diseased glomeruli to a large, protein-rich meal. J Clin Invest 1988;81:245-54.
23. Loon N, Shemesh O, Morelli E, Myers BD. Effect of angiotensin II infusion on the human glomerular filtration barrier. Am J Physiol 1989;257:F608-14.
24. Golbetz H, Black V, Shemesh O, Myers BD. Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans. Am J Physiol 1989;256:F44-51.
25. Morelli E, Loon N, Meyer T, Peters W, Myers BD. Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990;39:76-82.
26. De Zeeuw D, Heeg JE, de Jong PE. ACE inhibition improves glomerular permselectivity to proteins, not to dextrans [abstract]. J Am Soc Nephrol 1990;1:626.
27. Myers BD, Nelson RG, Williams GW, Bennet PH, Hardy SA, Berg RL, et al. Glomerular function in Pima indians with non-insulin dependent diabetes mellitus of recent onset. J Clin Invest 1991;88:524-30.
28. Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 1991;39:1267-73.
29. Remuzzi A, Perticucci E, Battaglia C, D'Amico G, Gentile MG, Remuzzi G. Low-protein diet and glomerular size-selective function in membranous glomerulopathy. Am J Kidney Dis 1991;3:317-22.
30. Guasch A, Hashimoto H, Sibley RK, Deen WM, Myers BD. Glomerular dysfunction in nephrotic humans with minimal changes or focal glomerulosclerosis. Am J Physiol 1991;260:F728-37.
31. Thomas DM, Hillis AN, Coles GA. Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics. Am J Kidney Dis 1991;1:38-43.
32. Wiegmann TB, Gish Herron K, Chonko AM, McDougall ML, Moore WV. Effect of angiotensin converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients. Diabetes 1992;41:62-7.
33. Scandling JD, Myers BD. Glomerular size-selectivity and micro-albuminuria in early diabetic disease. Kidney Int 1992;41:840-6.
34. Loon N, Chagnac A, Parra L, Schmidt K, Deen WM, Myers BD. Filtration dynamics and natriuretic response to volume expansion in humans. Am J Physiol 1992;263:F284-92.
35. Zietse R, Wenting GJ, Kramer P, Schalekamp MA, Weimar W. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clin Sci 1992;82:641-50.
36. Remuzzi A, Ruggenenti P, Mosconi L, Pata V, Viberti G, Remuzzi G. Effect of low dose enalapril on glomerular size-selectivity in human diabetic nephropathy. J Nephrol 1993;6:36-43.
37. Guasch A, Deen WM, Myers BD. Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. J Clin Invest 1993;92:2274-82.
38. Ikegaya N, Nagase M, Honda N, Kumagai H, Hishida A. Correlation between histologic features and glomerular permeability in membranous nephropathy and immunoglobulin A nephropathy. J Lab Clin Med 1994;123:94-101.
39. Ting RH, Kristal B, Myers BD. The biophysical basis of hypofiltration in nephrotic humans with membranous nephropathy. Kidney Int 1994;45:390-7.
40. Guasch A, Myers BD. Determinants of glomerular hypofiltration in nephrotic patients with minimal change nephropathy. J Am Soc Nephrol 1994;4:1571-81.
41. Hartmann A, Lund K, Hagel L, Holdaas H, Fauchald P, Reisoeter P, et al. Contrasting short-term effects of nifedipine on glomerular and tubular functions in glomerulonephritic patients. J Am Soc Nephrol 1994;5:1385-90.
42. Thomas DM, Coles GA, Griffiths DFR, Williams JD. Perms-electivity in thin membrane nephropathy. J Clin Invest 1994;93:1881-4.
43. Myers BD, Nelson RG, Tan M, Beck GJ, Bennet PH, Knowler WC, et al. Progression of overt nephropathy in non-insulin dependent diabetes. Kidney Int 1995;47:1781-9.
44. Ambalavanan S, Fauvel JP, Sibley RK, Myers BD. Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy. J Am Soc Nephrol 1996;7:290-8.
45. Koopman MG, Koomen GCM, van Acker BAC, Arisz L. Orcadian rhythm in glomerular transport of macromolecules through large pores and shunt pathways. Kidney Int 1996;49:1242-9.
46. Granath KA, Kvist BE. Molecular weight distribution analysis by gel chromatography on sephadex. J Chromatogr 1967;28:69-81.
47. Arturson G, Granath KA. Dextrans as test molecules in studies of the functional ultrastructure of biological membranes. Clin Chim Acta 1972;37:309-22.
48. Scott TA, Melvin EH. Determination of dextran with anthrone. Anal Chem 1953;25:1656-61.
49. Leypoldt JK, Frigon RP, DeVore KW, Henderson LW. A rapid renal clearance methodology for dextran. Kidney Int 1987;31:855-60.
50. Frigon RP, Leypoldt JK, Uyejl S, Henderson LW. Disparity between stokes radii of dextrans and proteins as determined by retention volume in gel permeation chromatography. Anal Chem 1983;55:1349-54.
51. Laurent TC, Killander J. A theory of gel filtration and its experimental verification. J Chromatogr 1964;14:319-30.
52. Oliver III JD, Anderson S, Troy JL, Brenner BM, Deen WM. Determination of glomerular size-selectivity in the normal rat with Ficoll. J Am Soc Nephrol 1992;3:214-28.
53. Watanabe N, Kamei S, Ohkubo A, Yamanake M, Ohsawa S, Makino K, et al. Urinary protein as measured with a pyragollol red-molybdate complex, manually and in a Hitachi 726 automated analyzer. Clin Chem 1986;32:1551-4.
54. 131I-hippuran. J Am Soc Nephrol 1996;7;567-72.
55. Hemmelder MH, de Zeeuw D, de Jong PE. Measurement of glomerular charge selectivity in non-diabetic renal disease. Nephrol Dial Transplant 1997;12(suppl 2):57-62.
56. Cameron JS, Blandford G. The simple assessment of selectivity in heavy proteinuria. Lancet 1966;2:242.
57. Hagel L, Hartmann A, Lund K. Analytical gel filtration for study of the glomerular filtration barrier function. J Chromatogr 1993;641:63-70.